Found: 2
Select item for more details and to access through your institution.
PAM staining intensity of primary neuroendocrine neoplasms is a potential prognostic biomarker.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-68071-6
- By:
- Publication type:
- Article
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 950, doi. 10.1002/onco.13923
- By:
- Publication type:
- Article